Bioorganic and Medicinal Chemistry Letters p. 1311 - 1316 (1999)
Update date:2022-08-05
Topics:
Williams, Peter D.
Bock, Mark G.
Evans, Ben E.
Freidinger, Roger M.
Gallicchio, Steven N.
Guidotti, Maribeth T.
Jacobson, Marlene A.
Michelle S, Kuo
Levy, Michelle R.
Edward V, Lis
Michelson, Stuart R.
Pawluczyk, Joseph M.
Perlow, Debra S.
Pettibone, Douglas J.
Quigley, Amy G.
Reiss, Duane R.
Salvatore, Christopher
Stauffer, Kenneth J.
Woyden, Carla J.
Structure-activity studies on the oxytocin antagonist 1 (L-371,257; K(i) = 9.3 nM) have led to the identification of a related series of compounds containing an ortho-trifluoroethoxyphenylacetyl core which are orally bioavailable and have significantly improved potency in vitro and in vivo, e.g., compound 8 (L-374,943; K(i) = 1.4 nM).
View MoreYueyang Hudex Pharmaceuticals Ltd.
Contact:0730-8748800
Address:Wujiang Bridge，Yueyang Economy & Technology Development Zone
Nanjing Chemzam Pharmtech Co., Ltd.
Contact:+86-25-86462165,+86-13915979898
Address:C5-1，6 Maiyue Road，Maigaoqiao，Nanjing，Jiangsu，China
Shandong Xinhua Pharmaceutical Co.,Ltd
website:http://www.xhzy.com
Contact:+86-533-2196801
Address:1 lutai road,zhangdian dis,Zibo City
Shanghai Gsyn Chemical Co.,Ltd.
Contact:86-021-67158290
Address:86-021-67158291
Shanghai ZaiQi Bio-Tech Co., Ltd.,
Contact:+86-21-5482 4098
Address:Bldg. No.7, No.201 MinYi Rd，Songjiang CaoHeJing High-Tech Park Shanghai 201516 P,R,China
Doi:10.1021/ja00271a033
(1986)Doi:10.1002/cjoc.201090280
(2010)Doi:10.1055/s-0035-1562528
(2016)Doi:10.1007/BF00869027
()Doi:10.1021/jo00966a004
(1972)Doi:10.1007/BF00849353
()
